Towards an effective genital herpes vaccine: past lessons and future prospects

Por Halford, William P.
Publicado em 2007

Alpha/Beta Interferon and Gamma Interferon Synergize To Inhibit the Replication of Herpes Simplex Virus Type 1

Por Sainz, Bruno, Halford, William P.
Publicado em 2002

Evidence that spontaneous reactivation of herpes virus does not occur in mice

Por Halford William P, Gebhardt Bryan M
Publicado em 2005-08-01

Optimized Viral Dose and Transient Immunosuppression Enable Herpes Simplex Virus ICP0-Null Mutants To Establish Wild-Type Levels of Latency In Vivo

Por Halford, William P., Schaffer, Priscilla A.
Publicado em 2000

ICP0 Is Required for Efficient Reactivation of Herpes Simplex Virus Type 1 from Neuronal Latency

Por Halford, William P., Schaffer, Priscilla A.
Publicado em 2001

Evidence that spontaneous reactivation of herpes virus does not occur in mice

Por Gebhardt, Bryan M, Halford, William P
Publicado em 2005

Herpes Simplex Virus 2 ICP0(−) Mutant Viruses Are Avirulent and Immunogenic: Implications for a Genital Herpes Vaccine

Por Halford, William P., Püschel, Ringo, Rakowski, Brandon
Publicado em 2010

Pan-HSV-2 IgG Antibody in Vaccinated Mice and Guinea Pigs Correlates with Protection against Herpes Simplex Virus 2

Por Halford, William P., Geltz, Joshua, Gershburg, Edward
Publicado em 2013

Green fluorescent protein is a quantitative reporter of gene expression in individual eukaryotic cells.

Por Soboleski, Mark R., Oaks, Jason, Halford, William P.
Publicado em 2005

ICP0 Dismantles Microtubule Networks in Herpes Simplex Virus-Infected Cells

Por Liu, Mingyu, Schmidt, Edward E., Halford, William P.
Publicado em 2010

Herpes Simplex Virus 2 (HSV-2) Infected Cell Proteins Are among the Most Dominant Antigens of a Live-Attenuated HSV-2 Vaccine

Por Geltz, Joshua J., Gershburg, Edward, Halford, William P.
Publicado no PLoS One (2015)

Re-Evaluating Natural Resistance to Herpes Simplex Virus Type 1

Por Halford, William P., Balliet, John W., Gebhardt, Bryan M.
Publicado em 2004

Re-evaluating the role of natural killer cells in innate resistance to herpes simplex virus type 1

Por Halford, William P, Maender, Jennifer L, Gebhardt, Bryan M
Publicado em 2005

Loss of the Type I Interferon Pathway Increases Vulnerability of Mice to Genital Herpes Simplex Virus 2 Infection

Por Conrady, Christopher D., Halford, William P., Carr, Daniel J. J.
Publicado em 2011

Antibodies Are Required for Complete Vaccine-Induced Protection against Herpes Simplex Virus 2

Por Halford, William P., Geltz, Joshua, Messer, Ronald J., Hasenkrug, Kim J.
Publicado no PLoS One (2015)

The UL13 and US3 Protein Kinases of Herpes Simplex Virus 1 Cooperate to Promote the Assembly and Release of Mature, Infectious Virions

Por Gershburg, Svetlana, Geltz, Joshua, Peterson, Karin E., Halford, William P., Gershburg, Edward
Publicado no PLoS One (2015)

Delivery of Interferon-γ by an Adenovirus Vector Blocks Herpes Simplex Virus Type 1 Reactivation in vitro and in vivo Independent of RNase L and Double-Stranded RNA-Dependent Prote...

Por Carr, Daniel J.J., Austin, Bobbie A., Halford, William P., Stuart, Patrick M.
Publicado em 2008

Investigation of the Mechanism by Which Herpes Simplex Virus Type 1 LAT Sequences Modulate Preferential Establishment of Latent Infection in Mouse Trigeminal Ganglia

Por Imai, Yumi, Apakupakul, Kathleen, Krause, Philip R., Halford, William P., Margolis, Todd P.
Publicado em 2009

A Live-Attenuated HSV-2 ICP0 (−) Virus Elicits 10 to 100 Times Greater Protection against Genital Herpes than a Glycoprotein D Subunit Vaccine

Por Halford, William P., Püschel, Ringo, Gershburg, Edward, Wilber, Andrew, Gershburg, Svetlana, Rakowski, Brandon
Publicado em 2011

The Herpes Simplex Virus-1 Transactivator Infected Cell Protein-4 Drives VEGF-A Dependent Neovascularization

Por Wuest, Todd, Zheng, Min, Efstathiou, Stacey, Halford, William P., Carr, Daniel J. J.
Publicado em 2011